Hironobu Saito is a graduate of the University of Chiba (Pharmaceutical Science: Master Course)and have gotten Dr.Degree in Chiba University,2009. He has worked for Sankyo Co., Ltd. for 24 years. He worked in Clinical Development Department for handling clinical trials mainly of cardiovascular agents in Japan In 2004, he became vice director of Clinical Development Department for management clinical trials. He arranged the clinical trials in Japan, Hong Kong and Singapore and works on regulatory issues for Japan , Asian and Central/South America countries. In 2005, He became senior vice director of Asia Drug Development and Registration Section & Clinical Development Department in Sankyo Co.,Ltd. From April of 2007, he became Director of Clinical Development Group of Asia Development Department of DaiichiSankyo. From April of 2012, he became Vice President of New Drug Regulatory Affairs of DaiichiSankyo.
In 1999, he started DIA activity as main program member of a workshop on clinical trials. In 2006, , he became vice-chairman of DIA advisory council of Japan. He was the presenter of APEC held in Japan in October of 2006. He has been the chairman of the DIA conferences in Japan for Asian New Drug Development for 5 years. He had the Outstanding Award of DIA in Atlanta on June,2007.